Navigating GLP-1 Use in Therapy

Source: APA MonitorGlucagon-like peptide-1 (GLP-1) receptor agonist medications, which include the drugs Ozempic and Wegovy, have been used to treat diabetes since 2005. But the drugs gained prominence when the FDA approved their use for weight loss, and celebrities from Oprah Winfrey to Elon Musk started touting them. As of November 2025, 18% of U.S. adults had taken a GLP-1 and 12% reported current use. Despite the benefits of GLP-1s, however, they also come...